These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34197935)

  • 21. Outbreak of NDM-1+CTX-M-15+DHA-1-producing Klebsiella pneumoniae high-risk clone in Spain owing to an undetectable colonised patient from Pakistan.
    Hernández-García M; Pérez-Viso B; León-Sampedro R; Navarro-San Francisco C; López-Fresneña N; Díaz-Agero C; Morosini MI; Ruiz-Garbajosa P; Cantón R
    Int J Antimicrob Agents; 2019 Aug; 54(2):233-239. PubMed ID: 31173865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
    Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;
    Clin Microbiol Infect; 2015 Dec; 21(12):1106.e1-8. PubMed ID: 26278669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis.
    Lübbert C; Becker-Rux D; Rodloff AC; Laudi S; Busch T; Bartels M; Kaisers UX
    Infection; 2014 Apr; 42(2):309-16. PubMed ID: 24217959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam.
    Papadimitriou-Olivgeris M; Bartzavali C; Lambropoulou A; Solomou A; Tsiata E; Anastassiou ED; Fligou F; Marangos M; Spiliopoulou I; Christofidou M
    J Antimicrob Chemother; 2019 Jul; 74(7):2051-2054. PubMed ID: 31002313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
    Brescini L; Morroni G; Valeriani C; Castelletti S; Mingoia M; Simoni S; Masucci A; Montalti R; Vivarelli M; Giacometti A; Barchiesi F
    BMC Infect Dis; 2019 Jul; 19(1):611. PubMed ID: 31299943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
    Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Protonotariou E; Poulou A; Politi L; Sgouropoulos I; Metallidis S; Kachrimanidou M; Pournaras S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2018 Sep; 52(3):331-337. PubMed ID: 29654892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
    Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
    Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation.
    Forcina A; Baldan R; Marasco V; Cichero P; Bondanza A; Noviello M; Piemontese S; Soliman C; Greco R; Lorentino F; Giglio F; Messina C; Carrabba M; Bernardi M; Peccatori J; Moro M; Biancardi A; Nizzero P; Scarpellini P; Cirillo DM; Mancini N; Corti C; Clementi M; Ciceri F
    Bone Marrow Transplant; 2017 Jan; 52(1):114-119. PubMed ID: 27668762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteremia with Carbapenemase-Producing
    Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J
    Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
    Zhang X; Chen D; Xu G; Huang W; Wang X
    PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Risk Clone of
    Del Rio A; Muresu N; Sotgiu G; Saderi L; Sechi I; Cossu A; Usai M; Palmieri A; Are BM; Deiana G; Cocuzza C; Martinelli M; Calaresu E; Piana AF
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270321
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage.
    Conte V; Monaco M; Giani T; D'Ancona F; Moro ML; Arena F; D'Andrea MM; Rossolini GM; Pantosti A;
    J Antimicrob Chemother; 2016 Dec; 71(12):3386-3391. PubMed ID: 27585968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit.
    Avgoulea K; Di Pilato V; Zarkotou O; Sennati S; Politi L; Cannatelli A; Themeli-Digalaki K; Giani T; Tsakris A; Rossolini GM; Pournaras S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.
    Lübbert C; Lippmann N; Busch T; Kaisers UX; Ducomble T; Eckmanns T; Rodloff AC
    Am J Infect Control; 2014 Apr; 42(4):376-80. PubMed ID: 24679563
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Lin L; Xiao X; Wang X; Xia M; Liu S
    Microb Drug Resist; 2020 Feb; 26(2):94-99. PubMed ID: 31433255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission.
    Papadimitriou-Olivgeris M; Marangos M; Fligou F; Christofidou M; Bartzavali C; Anastassiou ED; Filos KS
    J Antimicrob Chemother; 2012 Dec; 67(12):2976-81. PubMed ID: 22927316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
    Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
    J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.
    Spyridopoulou K; Psichogiou M; Sypsa V; Miriagou V; Karapanou A; Hadjihannas L; Tzouvelekis L; Daikos GL
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):102. PubMed ID: 32631456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study.
    Seo H; Kim HJ; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung J
    Clin Microbiol Infect; 2021 Aug; 27(8):1167.e1-1167.e8. PubMed ID: 33010443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.